These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25626081)

  • 1. miR‑27a suppresses the clonogenic growth and migration of human glioblastoma multiforme cells by targeting BTG2.
    Li WQ; Yu HY; Zhong NZ; Hou LJ; Li YM; He J; Liu HM; Xia CY; Lu YC
    Int J Oncol; 2015 Apr; 46(4):1601-8. PubMed ID: 25626081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles carry miR-27a-3p to promote drug resistance of glioblastoma to temozolomide by targeting BTG2.
    Chen L; Li Z; Hu S; Deng Q; Hao P; Guo S
    Cancer Chemother Pharmacol; 2022 Feb; 89(2):217-229. PubMed ID: 35039898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2.
    Zhou L; Liang X; Zhang L; Yang L; Nagao N; Wu H; Liu C; Lin S; Cai G; Liu J
    Oncotarget; 2016 Aug; 7(32):51943-51954. PubMed ID: 27409164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic cancer cell-derived exosomal microRNA-27a promotes angiogenesis of human microvascular endothelial cells in pancreatic cancer via BTG2.
    Shang D; Xie C; Hu J; Tan J; Yuan Y; Liu Z; Yang Z
    J Cell Mol Med; 2020 Jan; 24(1):588-604. PubMed ID: 31724333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AntagomiR-27a targets FOXO3a in glioblastoma and suppresses U87 cell growth in vitro and in vivo.
    Ge YF; Sun J; Jin CJ; Cao BQ; Jiang ZF; Shao JF
    Asian Pac J Cancer Prev; 2013; 14(2):963-8. PubMed ID: 23621269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9.
    Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y
    Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC01089 inhibits the progression of cervical cancer via inhibiting miR-27a-3p and increasing BTG2.
    Li S; Han Y; Liang X; Zhao M
    J Gene Med; 2021 Jan; 23(1):e3280. PubMed ID: 33025678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primate-specific miR-663 functions as a tumor suppressor by targeting PIK3CD and predicts the prognosis of human glioblastoma.
    Shi Y; Chen C; Zhang X; Liu Q; Xu JL; Zhang HR; Yao XH; Jiang T; He ZC; Ren Y; Cui W; Xu C; Liu L; Cui YH; Yu SZ; Ping YF; Bian XW
    Clin Cancer Res; 2014 Apr; 20(7):1803-13. PubMed ID: 24523440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-124 suppresses the migration and invasion of glioma cells in vitro via Capn4.
    Cai JJ; Qi ZX; Chen LC; Yao Y; Gong Y; Mao Y
    Oncol Rep; 2016 Jan; 35(1):284-90. PubMed ID: 26530859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-24 regulates the proliferation and invasion of glioma by ST7L via β-catenin/Tcf-4 signaling.
    Chen L; Zhang A; Li Y; Zhang K; Han L; Du W; Yan W; Li R; Wang Y; Wang K; Pu P; Jiang T; Jiang C; Kang C
    Cancer Lett; 2013 Feb; 329(2):174-80. PubMed ID: 23142218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes.
    Liu F; Gong J; Huang W; Wang Z; Wang M; Yang J; Wu C; Wu Z; Han B
    Oncogene; 2014 Oct; 33(40):4813-22. PubMed ID: 24166509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.
    Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X
    Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of miR-27a upregulation on thyroid cancer cells migration, invasion, and angiogenesis.
    Wang YL; Gong WG; Yuan QL
    Genet Mol Res; 2016 Dec; 15(4):. PubMed ID: 28002594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition.
    Coppola V; Musumeci M; Patrizii M; Cannistraci A; Addario A; Maugeri-Saccà M; Biffoni M; Francescangeli F; Cordenonsi M; Piccolo S; Memeo L; Pagliuca A; Muto G; Zeuner A; De Maria R; Bonci D
    Oncogene; 2013 Apr; 32(14):1843-53. PubMed ID: 22614007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA‑21 regulates the expression of BTG2 in HepG2 liver cancer cells.
    Mao B; Xiao H; Zhang Z; Wang D; Wang G
    Mol Med Rep; 2015 Oct; 12(4):4917-24. PubMed ID: 26151427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
    Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
    Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152.
    Yao Y; Ma J; Xue Y; Wang P; Li Z; Liu J; Chen L; Xi Z; Teng H; Wang Z; Li Z; Liu Y
    Cancer Lett; 2015 Apr; 359(1):75-86. PubMed ID: 25578780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-223 promotes the growth and invasion of glioblastoma cells by targeting tumor suppressor PAX6.
    Huang BS; Luo QZ; Han Y; Li XB; Cao LJ; Wu LX
    Oncol Rep; 2013 Nov; 30(5):2263-9. PubMed ID: 23970099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of microRNA-27a in human malignant glioma cell survival via targeting of prohibitin.
    Chen W; Qi J; Bao G; Wang T; Du CW; Wang MD
    Mol Med Rep; 2015 Jul; 12(1):1515-23. PubMed ID: 25777779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2.
    Chen L; Wang X; Wang H; Li Y; Yan W; Han L; Zhang K; Zhang J; Wang Y; Feng Y; Pu P; Jiang T; Kang C; Jiang C
    Eur J Cancer; 2012 Nov; 48(16):3104-11. PubMed ID: 22406049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.